Literature DB >> 7891105

Involvement of tau protein kinase I in paired helical filament-like phosphorylation of the juvenile tau in rat brain.

M Takahashi1, K Tomizawa, K Ishiguro, M Takamatsu, S C Fujita, K Imahori.   

Abstract

tau protein kinase I (TPKI) phosphorylates tau and forms paired helical filament epitopes in vitro. We studied temporal expression and histochemical distribution of tau phosphoserine epitopes at sites known to be phosphorylated by TPKI. Antibodies directed against phosphorylated Ser199 (anti-PS 199) or phosphorylated Ser396 (C5 or anti-PS 396) were used. TPKI is abundantly expressed in the young rat brain and the highly phosphorylated juvenile form of tau occurs in the same period. The activity peak of TPKI coincided with the high level of phosphorylation of Ser199 and Ser396 in juvenile tau at around postnatal day 8. By immunohistochemistry on the hippocampus and neocortex of 3-11-day-old rats, phosphorylated Ser396 was found in young axonal tracts and neuropil, where TPKI immunoreactivity was also detected. TPKI and phospho-Ser199 immunoreactivities were also detected in the perikarya of pyramidal neurons. TPKI immunoreactivity had declined to a low level and phosphorylated serine immunoreactivities were undetectable in the sections of adult brain. These findings implicate TPKI in paired helical filament-like phosphorylation of juvenile form of tau in the developing brain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7891105     DOI: 10.1046/j.1471-4159.1995.64041759.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

Review 1.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

2.  The crystal structure of the catalytic domain of tau tubulin kinase 2 in complex with a small-molecule inhibitor.

Authors:  Douglas J Marcotte; Kerri A Spilker; Dingyi Wen; Thomas Hesson; Thomas A Patterson; P Rajesh Kumar; Jayanth V Chodaparambil
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-03-02       Impact factor: 1.056

3.  Tau protein immunoreactivity in muscle fibers with rimmed vacuoles differs from that in regenerating muscle fibers.

Authors:  N Murakami; K Ishiguro; Y Ihara; I Nonaka; H Sugita; K Imahori
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 4.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

5.  Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.

Authors:  M-L Selenica; H S Jensen; A K Larsen; M L Pedersen; L Helboe; M Leist; J Lotharius
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

6.  TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, activity, localization and development.

Authors:  Michale Bouskila; Noor Esoof; Laurie Gay; Emily H Fang; Maria Deak; Michael J Begley; Lewis C Cantley; Alan Prescott; Kate G Storey; Dario R Alessi
Journal:  Biochem J       Date:  2011-07-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.